RNA modification: mechanisms and therapeutic targets

L Qiu, Q **g, Y Li, J Han - Molecular biomedicine, 2023 - Springer
RNA modifications are dynamic and reversible chemical modifications on substrate RNA
that are regulated by specific modifying enzymes. They play important roles in the regulation …

Renal cell carcinoma

E Jonasch, J Gao, WK Rathmell - Bmj, 2014 - bmj.com
The treatment of renal cell carcinoma (RCC) has changed greatly over the past 15 years.
Progress in the surgical management of the primary tumor and increased understanding of …

VHL, the story of a tumour suppressor gene

L Gossage, T Eisen, ER Maher - Nature Reviews Cancer, 2015 - nature.com
Abstract Since the Von Hippel–Lindau (VHL) disease tumour suppressor gene VHL was
identified in 1993 as the genetic basis for a rare disorder, it has proved to be of wide medical …

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide

S Walpole, AL Pritchard, CM Cebulla… - JNCI: Journal of the …, 2018 - academic.oup.com
Background The BRCA1-associated protein-1 (BAP1) tumor predisposition syndrome (BAP1-
TPDS) is a hereditary tumor syndrome caused by germline pathogenic variants in BAP1 …

Inhibitors of protein methyltransferases and demethylases

HU Kaniskan, ML Martini, J ** - Chemical reviews, 2018 - ACS Publications
Post-translational modifications of histones by protein methyltransferases (PMTs) and
histone demethylases (KDMs) play an important role in the regulation of gene expression …

Hypoxia-driven effects in cancer: characterization, mechanisms, and therapeutic implications

R Shi, C Liao, Q Zhang - Cells, 2021 - mdpi.com
Hypoxia, a common feature of solid tumors, greatly hinders the efficacy of conventional
cancer treatments such as chemo-, radio-, and immunotherapy. The depletion of oxygen in …

Critical roles of non-histone protein lysine methylation in human tumorigenesis

R Hamamoto, V Saloura, Y Nakamura - Nature Reviews Cancer, 2015 - nature.com
Several protein lysine methyltransferases and demethylases have been identified to have
critical roles in histone modification. A large body of evidence has indicated that their …

Genomic profiling in renal cell carcinoma

N Dizman, EJ Philip, SK Pal - Nature reviews nephrology, 2020 - nature.com
The treatment landscape of metastatic renal cell carcinoma (RCC) has been revolutionized
over the past two decades, bringing forth an era in which more than a dozen therapeutic …

Molecular genetics of clear-cell renal cell carcinoma

J Brugarolas - Journal of clinical oncology, 2014 - ascopubs.org
Renal cell carcinoma of clear-cell type (ccRCC) is an enigmatic tumor type, characterized by
frequent inactivation of the VHL gene (infrequently mutated in other tumor types) …

Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases

K Rai, R Pilarski, CM Cebulla… - Clinical …, 2016 - Wiley Online Library
The BRCA1‐associated protein‐1 (BAP1) tumor predisposition syndrome (BAP1‐TPDS) is a
recently identified hereditary cancer syndrome. Germline mutations in this tumor suppressor …